Oxidative stress in ageing and chronic degenerative pathologies: molecular mechanisms involved in counteracting oxidative stress and chronic inflammation

TS Leyane, SW Jere, NN Houreld - International journal of molecular …, 2022 - mdpi.com
Ageing and chronic degenerative pathologies demonstrate the shared characteristics of
high bioavailability of reactive oxygen species (ROS) and oxidative stress, chronic/persistent …

Oxidative stress, aging, and diseases

I Liguori, G Russo, F Curcio, G Bulli, L Aran… - … interventions in aging, 2018 - Taylor & Francis
Reactive oxygen and nitrogen species (RONS) are produced by several endogenous and
exogenous processes, and their negative effects are neutralized by antioxidant defenses …

Effects of statins on mitochondrial pathways

H Mollazadeh, E Tavana, G Fanni, S Bo… - Journal of Cachexia …, 2021 - Wiley Online Library
Statins are a family of drugs that are used for treating hyperlipidaemia with a recognized
capacity to prevent cardiovascular disease events. They inhibit β‐hydroxy β‐methylglutaryl …

Cellular senescence: molecular targets, biomarkers, and senolytic drugs

N Kudlova, JB De Sanctis, M Hajduch - International Journal of Molecular …, 2022 - mdpi.com
Cellular senescence is defined as irreversible cell cycle arrest caused by various processes
that render viable cells non-functional, hampering normal tissue homeostasis. It has many …

Coenzyme Q10 supplementation: Efficacy, safety, and formulation challenges

M Arenas‐Jal, JM Suñé‐Negre… - … reviews in food …, 2020 - Wiley Online Library
World population growth and aging are posing unprecedented challenges in sustaining the
health of 9.1 billion people that will be occupying the planet by 2050. Although …

Transcriptomic and proteomic landscape of mitochondrial dysfunction reveals secondary coenzyme Q deficiency in mammals

I Kühl, M Miranda, I Atanassov, I Kuznetsova, Y Hinze… - elife, 2017 - elifesciences.org
Dysfunction of the oxidative phosphorylation (OXPHOS) system is a major cause of human
disease and the cellular consequences are highly complex. Here, we present comparative …

Coenzyme Q10 in cardiovascular and metabolic diseases: current state of the problem

VI Zozina, S Covantev, OA Goroshko… - Current cardiology …, 2018 - ingentaconnect.com
The burden of cardiovascular and metabolic diseases is increasing with every year.
Although the management of these conditions has improved greatly over the years, it is still …

Coenzyme Q10: Clinical Applications beyond Cardiovascular Diseases

L Testai, A Martelli, L Flori, AFG Cicero, A Colletti - Nutrients, 2021 - mdpi.com
Coenzyme Q10 (CoQ10) is an essential cofactor in oxidative phosphorylation (OXPHOS),
present in mitochondria and cell membranes in reduced and oxidized forms. Acting as an …

[HTML][HTML] Coenzyme Q10 supplementation–In ageing and disease

J Aaseth, J Alexander, U Alehagen - Mechanisms of Ageing and …, 2021 - Elsevier
Abstract Coenzyme Q 10 (CoQ 10) is an essential component of the mitochondrial electron
transport chain. It is also an antioxidant in cellular membranes and lipoproteins. All cells …

Phyto-therapeutic and nanomedicinal approaches to cure Alzheimer's disease: present status and future opportunities

M Ovais, N Zia, I Ahmad, AT Khalil, A Raza… - Frontiers in aging …, 2018 - frontiersin.org
Alzheimer's disease (AD) is characterized by cognitive inability manifested due to the
accumulation of β-amyloid, formation of hyper phosphorylated neurofibrillary tangles, and a …